首页> 外文期刊>Medical dosimetry: official journal of the American Association of Medical Dosimetrists >Helical tomotherapy planning for lung cancer based on ventilation magnetic resonance imaging
【24h】

Helical tomotherapy planning for lung cancer based on ventilation magnetic resonance imaging

机译:基于通气磁共振成像的肺癌螺旋体层治疗计划

获取原文
获取原文并翻译 | 示例
       

摘要

To investigate the feasibility of lung ventilation-based treatment planning, computed tomography and hyperpolarized (HP) helium-3 (He-3) magnetic resonance imaging (MRI) ventilation images of 6 subjects were coregistered for intensity-modulated radiation therapy planning in Tomotherapy. Highly-functional lungs (HFL) and less-functional lungs (LFL) were contoured based on their ventilation image intensities, and a cylindrical planning-target-volume was simulated at locations adjacent to both HFL and LFL. Annals of an anatomy-based plan (Plan 1) and a ventilation-based plan (Plan 2) were generated. The following dosimetric parameters were determined and compared between the 2 plans: percentage of total/HFL volume receiving ≥20 Gy, 15 Gy, 10 Gy, and 5 Gy (TLV 20, HFLV 20, TLV 15, HFLV 15, TLV 10, HFLV 10, TLV 5, HFLV 5), mean total/HFL dose (MTLD/HFLD), maximum doses to all organs at risk (OARs), and target dose conformality. Compared with Plan 1, Plan 2 reduced mean HFLD (mean reduction, 0.8 Gy), MTLD (mean reduction, 0.6 Gy), HFLV 20 (mean reduction, 1.9%), TLV 20 (mean reduction, 1.5%), TLV 15 (mean reduction, 1.7%), and TLV 10 (mean reduction, 2.1%). P-values of the above comparisons are less than 0.05 using the Wilcoxon signed rank test. For HFLV 15, HFLV 10, TLV 5, and HTLV 5, Plan 2 resulted in lower values than plan 1 but the differences are not significant (P-value range, 0.063-0.219). Plan 2 did not significantly change maximum doses to OARs (P-value range, 0.063-0.563) and target conformality (P = 1.000). HP He-3 MRI of patients with lung disease shows a highly heterogeneous ventilation capacity that can be utilized for functional treatment planning. Moderate but statistically significant improvements in sparing functional lungs were achieved using helical tomotherapy plans.
机译:为了研究基于肺通气的治疗计划的可行性,计算机断层扫描和超极化(HP)He-3(He-3)磁共振成像(MRI)的6个受试者的通气图像被共同注册为Tomotherapy中的强度调制放射治疗计划。根据通气图像强度对高功能肺(HFL)和低功能肺(LFL)进行轮廓绘制,并在与HFL和LFL相邻的位置模拟圆柱规划目标体积。生成了基于解剖的计划(计划1)和基于通气的计划(计划2)的年鉴。确定了以下剂量学参数,并在两个计划之间进行了比较:≥20Gy,15 Gy,10 Gy和5 Gy的总/ HFL体积百分比(TLV 20,HFLV 20,TLV 15,HFLV 15,TLV 10,HFLV 10,TLV 5,HFLV 5),平均总/ HFL剂量(MTLD / HFLD),所有处于危险中的器官的最大剂量(OAR)和目标剂量的适应性。与计划1相比,计划2的平均HFLD(平均降低量为0.8 Gy),MTLD(平均降低量为0.6 Gy),HFLV 20(平均降低量为1.9%),TLV 20(平均降低量为1.5%),TLV 15(平均减少1.7%)和TLV 10(平均减少2.1%)。使用Wilcoxon符号秩检验,上述比较的P值小于0.05。对于HFLV 15,HFLV 10,TLV 5和HTLV 5,计划2的值低于计划1,但差异并不明显(P值范围为0.063-0.219)。计划2并未显着改变OAR的最大剂量(P值范围,0.063-0.563)和目标适形性(P = 1.000)。患有肺病的患者的HP He-3 MRI显示高度异质的通气能力,可用于功能治疗计划。使用螺旋型tomotherapy计划,在保留功能性肺部方面取得了中度但有统计学意义的改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号